These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 20064386

  • 21. Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease.
    Morris RJ, Parkyn CJ, Jen A.
    FEBS Lett; 2006 Oct 09; 580(23):5565-71. PubMed ID: 16884720
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prion genetics: new rules for a new kind of gene.
    Wickner RB, Edskes HK, Ross ED, Pierce MM, Baxa U, Brachmann A, Shewmaker F.
    Annu Rev Genet; 2004 Oct 09; 38():681-707. PubMed ID: 15355224
    [Abstract] [Full Text] [Related]

  • 29. Generation of prion transmission barriers by mutational control of amyloid conformations.
    Chien P, DePace AH, Collins SR, Weissman JS.
    Nature; 2003 Aug 21; 424(6951):948-51. PubMed ID: 12931190
    [Abstract] [Full Text] [Related]

  • 30. Conformational variations in an infectious protein determine prion strain differences.
    Tanaka M, Chien P, Naber N, Cooke R, Weissman JS.
    Nature; 2004 Mar 18; 428(6980):323-8. PubMed ID: 15029196
    [Abstract] [Full Text] [Related]

  • 31. C1q binding and complement activation by prions and amyloids.
    Sim RB, Kishore U, Villiers CL, Marche PN, Mitchell DA.
    Immunobiology; 2007 Mar 18; 212(4-5):355-62. PubMed ID: 17544820
    [Abstract] [Full Text] [Related]

  • 32. Protein misfolding and neurodegeneration.
    Soto C, Estrada LD.
    Arch Neurol; 2008 Feb 18; 65(2):184-9. PubMed ID: 18268186
    [Abstract] [Full Text] [Related]

  • 33. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB, Kushnirov VV, Ter-Avanesian MD.
    Mol Biol (Mosk); 2007 Feb 18; 41(2):346-54. PubMed ID: 17514901
    [Abstract] [Full Text] [Related]

  • 34. Do amyloids remember their origin? New insights into the prion species barrier.
    Chernoff YO.
    Mol Cell; 2004 Apr 23; 14(2):147-8. PubMed ID: 15099512
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
    Nandi PK, Nicole JC.
    J Mol Biol; 2004 Nov 26; 344(3):827-37. PubMed ID: 15533448
    [Abstract] [Full Text] [Related]

  • 40. Prions, prionoid complexes and amyloids: the bad, the good and something in between.
    Hafner Bratkovič I.
    Swiss Med Wkly; 2017 Nov 26; 147():w14424. PubMed ID: 28421568
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.